[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Daniel DeAngelo, MD, PhD

Specialities: Myelodysplastic Syndromes, Myelofibrosis

Spoken languages: English

Clinical Expertise

  • Myelofibrosi
  • Myelodysplastic Syndromes

About

I am involved with clinical protocols designed to treat patients with de novo or relapsed acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML) as well as novel therapeutic approaches for the patient with myelodysplasia.

My current research interests include novel immunotherapeutic approaches to the treatment of acute myelogenous leukemia and myelodysplasia. I am currently developing leukemia tumor vaccines from patients with AML or advanced myelodysplasia and will be assaying for immunological and serological responses.

Location

Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA

newsletter icon

Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie
Bristol Myers Squibb

Follow Us

facebook instagram youtube